article
22 June 2021 | By Dr Harri Sihto (University of Helsinki), Dr Katja Ivanitskiy (Sartar Therapeutics), Professor Olli Kallioniemi (Sartar Therapeutics)
A new promising sarcoma target, phosphodiesterase 3A (PDE3A), and drugs targeting it have been identified by researchers at the University of Helsinki. Dr Katja Ivanitskiy, Dr Harri Sihto and Professor Olli Kallioniemi outline emerging evidence that indicates PDE3A protein-targeting compounds may induce sarcoma cell death by acting as a molecular…